Effect of wheat leaf ribonuclease on tumor cells and tissues

Jirí Skvor1, Petra Lipovová, Pavla Poucková

  • 1Laboratory of Genetics, Department of Anthropology, Faculty of Science of the Charles University, Prague, Czech Republic.

Anti-Cancer Drugs
|August 24, 2006
PubMed

Insights

Wheat leaf ribonuclease shows antitumor effects in vivo, reducing tumor size in mice. Despite lower antiproliferative activity in vitro, this plant-derived enzyme demonstrates potential as an antitumor drug.

Area of Science:

  • Biochemistry
  • Oncology
  • Pharmacology

Background:

  • Ribonucleases (RNases) are enzymes with potential therapeutic applications.
  • Plant-derived RNases have been explored for their biological activities.
  • Understanding the antitumor potential of wheat leaf ribonuclease (WLR) compared to animal RNases is crucial.

Purpose of the Study:

  • To evaluate the antiproliferative and antitumor effects of WLR.
  • To compare the efficacy of WLR with bovine seminal ribonuclease (BSR) and other RNases.
  • To investigate the immunogenicity and immunosuppressive effects of WLR.

Main Methods:

  • In vitro antiproliferative assays using human ML-2 cell line.
  • In vivo antitumor studies in athymic nude mice bearing human melanoma tumors.
  • Immunological cross-reactivity tests and antibody inactivation assays.

Main Results:

  • WLR exhibited negligible antiproliferative activity in vitro compared to BSR.
  • Significant tumor size reduction was observed in mice treated with WLR (39%) and PEG-conjugated WLR (28%) in vivo.
  • WLR demonstrated structural similarity to animal RNases, weaker immunogenicity than BSR, and comparable immunosuppressive effects.

Conclusions:

  • Wheat leaf ribonuclease possesses significant in vivo antitumor activity.
  • WLR shows promise as a potential antitumor agent, warranting further investigation.
  • This study is the first to compare plant ribonuclease's antitumor effects against animal RNases in vivo.

Related Concept Videos

The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...